Lupin makes impairment provision for Gavis

Lupin took a hit worth Rs 1,464.35 crore on US-based Gavis, which it acquired in 2015 for $880 million (Rs 5,610 crore then).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news